Directorate change

31 OCTOBER 2012

NORTHERN VENTURE TRUST PLC

DIRECTORATE CHANGE

Northern Venture Trust PLC ("the Company") is pleased to announce that at a board meeting held on 31 October 2012, Mr Simon Constantine was appointed to the board as a non-executive director with immediate effect.

Mr Constantine is aged 53 and has extensive business management experience at board level, particularly in the healthcare and life sciences sectors, and co-led the management buy-in and subsequent trade sale of Life Sciences International plc.  He has served as a non-executive director of a number of venture capital and private equity-backed businesses as well as having had more than 20 years' experience as a director of publicly listed companies.  He is currently chairman of Capstone Foster Care Limited and Reinnervate Limited and is a non-executive director of publicly listed Bioquell PLC.

Mr Constantine has a beneficial interest (including the interest of a connected person) in 105,000 ordinary shares in the Company, representing approximately 0.15 per cent of the Company's issued ordinary share capital.

There are no disclosures to be made under paragraph 9.6.13(1)-(6) of the Listing Rules in relation to Mr Constantine's appointment.

Enquiries:

Christopher Mellor, Company Secretary - 0191 244 6000
Website:  www.nvm.co.uk

Neither the contents of the NVM Private Equity Limited website nor the contents of any website accessible from hyperlinks on the NVM Private Equity Limited website (or any other website) is incorporated into, or forms part of, this announcement.

---

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Northern Venture Trust PLC via Thomson Reuters ONE

HUG#1654127